Home > Financial Ratios > KWALITY PHARMACEUTICALS

KWALITY PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
KWALITY PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for KWALITY PHARMACEUTICALS
Please provide your vote to see the results

KWALITY PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 7.03-63.65475.4870.509.45

What is the latest Core EBITDA Growth ratio of KWALITY PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of KWALITY PHARMACEUTICALS is 7.03 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar20247.03
Mar2023-63.65
Mar2022475.48
Mar202170.50
Mar20209.45

How is Core EBITDA Growth of KWALITY PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 7.03
Positive
Mar2023 -63.65
Negative
Mar2022 475.48
574.44
Mar2021 70.5
646.03
Mar2020 9.45 -

Other Financial Ratios of KWALITY PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of KWALITY PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS ₹785.7 Cr -3.1% -16.6% 68.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,003.0 Cr -0.2% -1% 9.8% Stock Analytics
DIVIS LABORATORIES ₹154,939.0 Cr -2.1% 1.5% 61.3% Stock Analytics
CIPLA ₹117,835.0 Cr -0% 2% -0.5% Stock Analytics
DR REDDYS LABORATORIES ₹99,784.6 Cr -1.4% -6.1% -4% Stock Analytics
ZYDUS LIFESCIENCES ₹90,722.1 Cr -5.2% -4.7% 8.9% Stock Analytics


KWALITY PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS

-3.1%

-16.6%

68.5%

SENSEX

-2.5%

-1.4%

6.1%


You may also like the below Video Courses